Steven M. Finegan

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Andrew P. Tomaras, Jared L. Crandon, Craig J. McPherson et al. · Antimicrobial Agents and Chemotherapy · 2013 · 110 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam

Craig J. McPherson, Lisa Aschenbrenner, Brian M. Lacey et al. · Antimicrobial Agents and Chemotherapy · 2012 · 89 citations · Full text

Life Sciences, Medicinal Chemistry, Antimicrobial Resistance +16

Preparation, Gram-Negative Antibacterial Activity, and Hydrolytic Stability of Novel Siderophore-Conjugated Monocarbam Diols

Mark E. Flanagan, Steven J. Brickner, Manjinder S. Lall et al. · ACS Medicinal Chemistry Letters · 2011 · 71 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models

D Girard, Steven M. Finegan, Michael W. Dunne et al. · Journal of Antimicrobial Chemotherapy · 2005 · 69 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections

Thomas V. Magee, Sharon L. Ripp, Bryan Li et al. · Journal of Medicinal Chemistry · 2009 · 54 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15